Yüklüyor......
Liposomal Amphotericin B and Leishmaniasis: Dose and Response
Liposomal amphotericin B has been used with increasing frequency to treat visceral leishmaniasis (VL). It is the treatment of choice for immunocompetent patients in the Mediterranean region and the preferred drug for HIV/VL co-infection. Although there is a regional variation in the susceptibility o...
Kaydedildi:
| Asıl Yazarlar: | , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Medknow Publications
2010
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2889656/ https://ncbi.nlm.nih.gov/pubmed/20606972 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0974-777X.62886 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|